DE102014106489A1 - Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit - Google Patents
Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit Download PDFInfo
- Publication number
- DE102014106489A1 DE102014106489A1 DE102014106489.5A DE102014106489A DE102014106489A1 DE 102014106489 A1 DE102014106489 A1 DE 102014106489A1 DE 102014106489 A DE102014106489 A DE 102014106489A DE 102014106489 A1 DE102014106489 A1 DE 102014106489A1
- Authority
- DE
- Germany
- Prior art keywords
- dialysis
- fluid
- liquid
- dialysis fluid
- wavelength
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 98
- 239000007788 liquid Substances 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 41
- 239000000385 dialysis solution Substances 0.000 claims abstract description 144
- 238000010521 absorption reaction Methods 0.000 claims abstract description 74
- 230000008033 biological extinction Effects 0.000 claims abstract description 73
- 238000000502 dialysis Methods 0.000 claims abstract description 61
- 238000004458 analytical method Methods 0.000 claims abstract description 53
- 239000002441 uremic toxin Substances 0.000 claims abstract description 43
- 238000012545 processing Methods 0.000 claims abstract description 20
- 239000003344 environmental pollutant Substances 0.000 claims abstract description 19
- 231100000719 pollutant Toxicity 0.000 claims abstract description 19
- 239000012530 fluid Substances 0.000 claims abstract description 15
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 150
- 229940109239 creatinine Drugs 0.000 claims description 75
- 230000003287 optical effect Effects 0.000 claims description 48
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 41
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 41
- 210000004369 blood Anatomy 0.000 claims description 41
- 239000008280 blood Substances 0.000 claims description 41
- 229940116269 uric acid Drugs 0.000 claims description 41
- 230000008859 change Effects 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 210000002381 plasma Anatomy 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000010979 pH adjustment Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 34
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 28
- 238000002835 absorbance Methods 0.000 description 24
- 238000001228 spectrum Methods 0.000 description 22
- 239000004202 carbamide Substances 0.000 description 13
- 230000000875 corresponding effect Effects 0.000 description 9
- 238000005868 electrolysis reaction Methods 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 239000013060 biological fluid Substances 0.000 description 7
- 238000001631 haemodialysis Methods 0.000 description 7
- 230000000322 hemodialysis Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241001580017 Jana Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- -1 urine Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1617—Control or regulation using measurements made during a temporary variation of a characteristic of the fresh dialysis fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/255—Details, e.g. use of specially adapted sources, lighting or optical systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/3103—Atomic absorption analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
- A61M2205/3313—Optical measuring means used specific wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/85—Investigating moving fluids or granular solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014106489.5A DE102014106489A1 (de) | 2014-05-08 | 2014-05-08 | Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit |
| EP15157737.6A EP2942614B1 (de) | 2014-05-08 | 2015-03-05 | Vorrichtung und vorrichtungs-steuerungsverfahren zur quantitativen konzentrationsbestimmung ausgewählter aus einem patientenkörper ausgefilterter substanzen in einer flüssigkeit |
| US14/691,208 US9423338B2 (en) | 2014-05-08 | 2015-04-20 | Apparatus and apparatus control method for the quantitative concentration determination of selected substances filtered out of a patient's body in a fluid |
| CN201510224865.0A CN105092504B (zh) | 2014-05-08 | 2015-05-05 | 体外体液净化设备和设备控制方法 |
| CN201520286131.0U CN204882361U (zh) | 2014-05-08 | 2015-05-05 | 用于定量测定在从身体中分泌/提取的流体或体外血液净化流体中的所选或可选物质的设备 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014106489.5A DE102014106489A1 (de) | 2014-05-08 | 2014-05-08 | Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102014106489A1 true DE102014106489A1 (de) | 2015-11-12 |
Family
ID=52633120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102014106489.5A Pending DE102014106489A1 (de) | 2014-05-08 | 2014-05-08 | Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9423338B2 (zh) |
| EP (1) | EP2942614B1 (zh) |
| CN (2) | CN204882361U (zh) |
| DE (1) | DE102014106489A1 (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015122615A1 (de) * | 2015-12-22 | 2017-06-22 | B. Braun Avitum Ag | Vorrichtung und Verfahren zur quantitativen Bestimmung einer Stoffkonzentration in einer Flüssigkeit |
| CN113447453A (zh) * | 2021-07-15 | 2021-09-28 | 昆明理工大学 | 一种尿酸酶模拟酶的制备方法及应用 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102014106489A1 (de) * | 2014-05-08 | 2015-11-12 | B. Braun Avitum Ag | Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit |
| EP3539586B1 (en) | 2014-10-10 | 2022-08-24 | NxStage Medical Inc. | Flow balancing methods |
| DE102015120216A1 (de) * | 2015-11-23 | 2017-05-24 | B. Braun Avitum Ag | Verfahren zur Kalibrierung eines Messsignals und zum Nachführen einer quantitativen Größe |
| US10898635B2 (en) | 2016-07-18 | 2021-01-26 | Nxstage Medical, Inc. | Flow balancing devices, methods, and systems |
| EP3506962B1 (en) | 2016-08-30 | 2023-11-22 | NxStage Medical, Inc. | Parameter monitoring in medical treatment systems |
| EP3376212B1 (en) * | 2017-03-17 | 2020-01-29 | Ricoh Company Ltd. | Chemiluminescence analyzer, blood purification apparatus, and blood purification system |
| JP7017077B2 (ja) * | 2017-03-17 | 2022-02-08 | 株式会社リコー | 化学発光分析装置、血液浄化装置、及び血液浄化システム |
| CN112805044A (zh) * | 2018-08-23 | 2021-05-14 | 尼普洛株式会社 | 细胞外液量计算装置和细胞外液量计算方法 |
| US10765793B1 (en) * | 2019-06-27 | 2020-09-08 | Fresenius Medical Care Holdings, Inc. | Ammonia detection in dialysis systems |
| TWI762077B (zh) * | 2020-12-10 | 2022-04-21 | 瑞愛生醫股份有限公司 | 尿酸檢測裝置 |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2658101A1 (de) | 1975-12-31 | 1977-07-14 | Gambro Ag | Verfahren zur messung der konzentration von niedrigmolekularen verbindungen in komplexen medien, vorzugsweise bei medizinischen behandlungen, und vorrichtung zur durchfuehrung des verfahrens |
| WO1996018096A1 (en) * | 1994-12-09 | 1996-06-13 | United Utilities Plc | Quantitative detection of chemical species |
| EP0911043A1 (de) * | 1997-10-27 | 1999-04-28 | Polaschegg, Hans-Dietrich, Dr.techn. | Verfahren zur Messung von Leistungsparametern von Stoff- und Energieaustausch Modulen |
| US5928180A (en) * | 1997-03-25 | 1999-07-27 | Krivitski; Nikolai M. | Method and apparatus for real time monitoring of blood volume in a filter |
| GB2390420A (en) | 2002-07-02 | 2004-01-07 | James Samsoondar | Method for calibrating spectrophotometric apparatus |
| EP1083948B1 (en) | 1998-06-04 | 2004-03-31 | Althin Medical Ab | Method for determining waste products in the dialysis liquid in dialysis treatment |
| US7002670B2 (en) | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
| US20080015434A1 (en) | 2001-05-22 | 2008-01-17 | Alfred E. Mann Institute For Biomedical Engineering At The University Of S. California | Measurement of Cardiac Output and Blood Volume by Non-Invasive Detection of Indicator Dilution for Hemodialysis |
| WO2009071102A1 (en) | 2007-12-04 | 2009-06-11 | Tallinn University Of Technology | Optical method and device for measuring concentrations of substances in biological fluids |
| WO2010024963A1 (en) | 2008-08-28 | 2010-03-04 | Baxter International Inc. | In-line sensors for dialysis applications |
| WO2011147425A1 (en) * | 2010-05-27 | 2011-12-01 | Tallinn University Of Technology | Method and device for measuring and monitoring concentration of substances in a biological fluid |
| DE102011101193A1 (de) | 2011-05-11 | 2012-11-15 | Ldiamon As | Verfahren und Nachweisvorrichtung zur Bestimmung des Harnsäure- und Kreatinin-Gehalts |
| DE102011102962A1 (de) * | 2011-05-23 | 2012-11-29 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Erkennung eines Betriebszustandes einer extrakorporalen Blutbehandlung |
| WO2014026828A1 (de) * | 2012-08-15 | 2014-02-20 | Siemens Healthcare Diagnostics Products Gmbh | Verfahren zur optischen bestimmung mindestens eines analyten in einer probe |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5387524A (en) * | 1993-06-23 | 1995-02-07 | Mitsubishi Materials Corporation | Method for quantitative flow injection analysis of metals in body fluids |
| US7639361B2 (en) * | 2007-05-14 | 2009-12-29 | Watkins Manufacturing Corporation | Apparatus for measuring chemical levels using pH shift |
| US7671994B2 (en) * | 2007-05-14 | 2010-03-02 | Watkins Manufacturing Corporation | Method for measuring chemical levels using pH shift |
| WO2011113020A1 (en) * | 2010-03-11 | 2011-09-15 | Glumetrics, Inc. | Measurement devices and methods for measuring analyte concentration incorporating temperature and ph correction |
| WO2013070172A1 (en) * | 2011-11-08 | 2013-05-16 | Temasek Polytechnic | Sensing system for detecting a substance in a dialysate |
| DE102014106489A1 (de) * | 2014-05-08 | 2015-11-12 | B. Braun Avitum Ag | Vorrichtung und Vorrichtungs-Steuerungsverfahren zur quantitativen Konzentrationsbestimmung ausgewählter aus einem Patientenkörper ausgefilterter Substanzen in einer Flüssigkeit |
-
2014
- 2014-05-08 DE DE102014106489.5A patent/DE102014106489A1/de active Pending
-
2015
- 2015-03-05 EP EP15157737.6A patent/EP2942614B1/de active Active
- 2015-04-20 US US14/691,208 patent/US9423338B2/en active Active
- 2015-05-05 CN CN201520286131.0U patent/CN204882361U/zh active Active
- 2015-05-05 CN CN201510224865.0A patent/CN105092504B/zh active Active
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2658101A1 (de) | 1975-12-31 | 1977-07-14 | Gambro Ag | Verfahren zur messung der konzentration von niedrigmolekularen verbindungen in komplexen medien, vorzugsweise bei medizinischen behandlungen, und vorrichtung zur durchfuehrung des verfahrens |
| WO1996018096A1 (en) * | 1994-12-09 | 1996-06-13 | United Utilities Plc | Quantitative detection of chemical species |
| US5928180A (en) * | 1997-03-25 | 1999-07-27 | Krivitski; Nikolai M. | Method and apparatus for real time monitoring of blood volume in a filter |
| EP0911043A1 (de) * | 1997-10-27 | 1999-04-28 | Polaschegg, Hans-Dietrich, Dr.techn. | Verfahren zur Messung von Leistungsparametern von Stoff- und Energieaustausch Modulen |
| EP1083948B1 (en) | 1998-06-04 | 2004-03-31 | Althin Medical Ab | Method for determining waste products in the dialysis liquid in dialysis treatment |
| US20080015434A1 (en) | 2001-05-22 | 2008-01-17 | Alfred E. Mann Institute For Biomedical Engineering At The University Of S. California | Measurement of Cardiac Output and Blood Volume by Non-Invasive Detection of Indicator Dilution for Hemodialysis |
| US7002670B2 (en) | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
| GB2390420A (en) | 2002-07-02 | 2004-01-07 | James Samsoondar | Method for calibrating spectrophotometric apparatus |
| WO2009071102A1 (en) | 2007-12-04 | 2009-06-11 | Tallinn University Of Technology | Optical method and device for measuring concentrations of substances in biological fluids |
| WO2010024963A1 (en) | 2008-08-28 | 2010-03-04 | Baxter International Inc. | In-line sensors for dialysis applications |
| WO2011147425A1 (en) * | 2010-05-27 | 2011-12-01 | Tallinn University Of Technology | Method and device for measuring and monitoring concentration of substances in a biological fluid |
| DE102011101193A1 (de) | 2011-05-11 | 2012-11-15 | Ldiamon As | Verfahren und Nachweisvorrichtung zur Bestimmung des Harnsäure- und Kreatinin-Gehalts |
| WO2012152514A1 (de) * | 2011-05-11 | 2012-11-15 | Ldiamon As | Verfahren und nachweisvorrichtung zur bestimmung des harnsäure- und kreatinin-gehalts |
| DE102011102962A1 (de) * | 2011-05-23 | 2012-11-29 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Erkennung eines Betriebszustandes einer extrakorporalen Blutbehandlung |
| WO2014026828A1 (de) * | 2012-08-15 | 2014-02-20 | Siemens Healthcare Diagnostics Products Gmbh | Verfahren zur optischen bestimmung mindestens eines analyten in einer probe |
Non-Patent Citations (3)
| Title |
|---|
| "Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blond urea, dialysate urea and ionic dialysance", Nephrol Dial Transplant (2006) 21: 2225-2231 doi:10.1093/ndt/gf1147, Advance Access publication 12 April 2006 |
| "Optical measurement of creatinine in spent dialysate", Ruth Tomson, Ivo Fridolin, Frederik Uhlin, Jana Holmar, Kai Lauri and Merike Luman, www.dustri.com/nc/article-response-page.html?artld=10137&doi= |
| "Real-time Kt/V determination by ultraviolet absorbance in spent dialysate: technique validation", Kidney International advance online publication, 14-July 2010; doi:10.1038/ki.2010.216 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015122615A1 (de) * | 2015-12-22 | 2017-06-22 | B. Braun Avitum Ag | Vorrichtung und Verfahren zur quantitativen Bestimmung einer Stoffkonzentration in einer Flüssigkeit |
| CN113447453A (zh) * | 2021-07-15 | 2021-09-28 | 昆明理工大学 | 一种尿酸酶模拟酶的制备方法及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20150323447A1 (en) | 2015-11-12 |
| CN204882361U (zh) | 2015-12-16 |
| US9423338B2 (en) | 2016-08-23 |
| EP2942614A1 (de) | 2015-11-11 |
| EP2942614B1 (de) | 2021-01-20 |
| CN105092504B (zh) | 2020-12-22 |
| CN105092504A (zh) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2942614B1 (de) | Vorrichtung und vorrichtungs-steuerungsverfahren zur quantitativen konzentrationsbestimmung ausgewählter aus einem patientenkörper ausgefilterter substanzen in einer flüssigkeit | |
| DE69916053T2 (de) | Verfahren und bestimmung von abfallprodukten in dialyseflüssigkeiten während dialysebehandlungen | |
| EP2579910B1 (de) | Vorrichtung zur extrakorporalen blutbehandlung mit einer messeinrichtung zur bestimmung der lumineszenz der verbrauchten dialysierflüssigkeit | |
| EP2799097B1 (de) | Vorrichtung zur extrakorporalen Blutbehandlung | |
| DE102010034626A1 (de) | Vorrichtung zur extrakorporalen Blutbehandlung | |
| EP1053759B1 (de) | Verfahren zur Steuerung einer Vorrichtung zur partiellen Dialysatsammlung | |
| EP1927370B1 (de) | Verfahren zur Bestimmung von Parametern der Hämodialyse und Blutbehandlungsvorrichtung mit einer Einrichtung zur Bestimmung von Parametern der Hämodialyse | |
| EP0246451B1 (de) | Vorrichtung zur Bestimmung von Gaspartialdrücken im Blut | |
| EP3431118B1 (de) | Vorrichtung zur durchführung einer isonaträmischen dialyse | |
| DE102011088235A1 (de) | Probenvorbereitungseinrichtung für eine Analyseeinrichtung zur Bestimmung einer Messgröße einer flüssigen Probe | |
| EP2783715A1 (de) | Verfahren zur Erfassung einer Rezirkulation in einem arteriovenösen Shunt während laufender Hämodialyse und Dialysesystem | |
| DE102009017304A1 (de) | Vorrichtung und Verfahren zur Messung eines Blutbestandteils im Blut für eine extrakorporale Blutbehandlungsvorrichtung | |
| EP2579911B1 (de) | Dialyseanordnung mit einer nachweisvorrichtung | |
| EP2707697A1 (de) | Verfahren und nachweisvorrichtung zur bestimmung des harnsäure- und kreatinin-gehalts | |
| EP2397167A1 (de) | Vorrichtung zur extrakorporalen Blutbehandlung mit einer Messeinrichtung zur Bestimmung der Lumineszenz der verbrauchten Dialysierflüssigkeit | |
| DE102011008482A1 (de) | UV-Detektoranordnung | |
| DE1802671A1 (de) | Verfahren und Vorrichtung zur selbsttaetigen Bestimmung der osmotischen Resistenz roter Blutkoerperchen | |
| WO2015063113A1 (de) | Verfahren und vorrichtung zur erfassung der hämolyse oder zur bestimmung eines den einfluss der hämolyse auf eine messung des hämatokrits korrigierenden korrekturfaktors | |
| WO2012003989A2 (de) | Verfahren und vorrichtung zum bestimmen der konzentration eines blutbestandteils in einer mit blut gefüllten schlauchleitung | |
| EP2696911B1 (de) | Verfahren und vorrichtung zur anpassung der mittelmolekularen reinigungsleistung durch einstellung des substitutionsflusses | |
| EP2783714B1 (de) | Verfahren und Vorrichtung zur Bestimmung eines Rezirkulationszustands | |
| EP2746771B1 (de) | Vorrichtung zur bestimmung von abfallprodukten wie indoxyl sulfate in der dialyse | |
| DE102017008631A1 (de) | Anordnung zur Filterung von Blut, insbesondere im Rahmen einer extrakorporalen Leberersatztherapie, sowie Verfahren zum Betrieb serselben | |
| EP2735323A1 (de) | Verfahren und Vorrichtung zur Erkennung einer verminderten Dialyseleistung verursacht durch Verklottung | |
| DE19649775C1 (de) | Verfahren zur in-vivo-Bestimmung des wäßrigen Blutanteils sowie daraus abgeleiteter Größen bei der Hämodialyse und Verwendung einer Vorrichtung zur Durchführung des Verfahrens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R163 | Identified publications notified | ||
| R082 | Change of representative |
Representative=s name: WINTER, BRANDL - PARTNERSCHAFT MBB, PATENTANWA, DE Representative=s name: WINTER, BRANDL, FUERNISS, HUEBNER, ROESS, KAIS, DE |
|
| R012 | Request for examination validly filed |